This Biotech’s Stock Soaring After FDA Official Exits
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
Deciding between broad market and sector funds depends on diversification needs and risk tolerance. This guide compares outcomes and helps you decide.
28,547 articlesBiotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
Former President Trump warns Netflix of consequences over a board-seat dispute, triggering a rapid market reaction as...
Oil climbs above $95 as equities pause, with the S&P 500 near unchanged. Delta raises its Q1 revenue outlook, while t...
XRP continues to slide in March 2026 despite regulatory wins and Brazil expansion, with traders weighing macro risks,...
U.S. stocks rebounded from early weakness as oil prices surged on geopolitical tensions. The Nasdaq Composite led the...
A leading market analyst argues SpaceX could see a 50% decline in its stock within six months if it goes public, citi...
A hedge-fund short report rattled Bloom Energy, triggering a brief stock drop before a swift rebound. Investors are w...
A notable fund adds Masimo stock, signaling confidence in noninvasive monitoring tech. This analysis breaks down the ...
Markets show crypto longer single industry dynamics fading as four distinct lanes diverge. Bitcoin, stablecoins, toke...
A calm financial plan can come from tough life moments. This article uses the quiet split of a public figure to illus...
Ford stock surged 8% on Friday, easily outpacing General Motors and Stellantis as investors focus on Ford Energy and ...
As defense budgets stabilize and technology explodes, investors are re-pricing defense names. This piece examines why...